Molecular Cancer Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.8 | Q1 | 80.2% | 1.759 | Q1 | 94.0% |
| 2024 | 4.7 | Q1 | 76.7% | 1.748 | Q1 | 94.1% |
| 2023 | 4.1 | Q2 | 68.7% | 1.660 | Q1 | 93.9% |
| 2022 | 5.2 | Q2 | 73.8% | 1.668 | Q1 | 94.2% |
| 2021 | 6.3 | Q2 | 76.9% | 1.805 | Q1 | 95.1% |
| 2020 | — | — | 2.273 | Q1 | 96.4% | |
| 2019 | — | — | 2.389 | Q1 | 96.8% | |
| 2018 | — | — | 2.381 | Q1 | 96.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1557-3125
ISSN
1541-7786
country
UScoverage
2002-2026